Ascribe Bioscience
Ithaca
About Ascribe Bioscience
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: ascribebio.com
- Phone: 607-703-9083
Industries & Categories
Agriculture, AgTech, Biotechnology, Farming
Social Profiles
Canonical: https://fsome.com/organization/ascribe-bioscience-98558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.